North China Pharmaceutical Co Ltd (600812.SS)
20 Sep 2018
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|44||2015||Chairman of the Board, Finance Director, Chief Accounting Officer, Secretary of the Board|
|50||2009||Vice Chairman of the Board, General Manager|
|47||2009||Deputy General Manager, Director|
|45||2007||Deputy General Manager|
|45||2012||Deputy General Manager|
- China stocks ease after three straight days of gain
- Hong Kong stocks follow Wall Street higher; China little changed
- BRIEF-North China Pharmaceutical Gets Approval To Issue 2.0 Billion Yuan Commercial Paper
- BRIEF-North China Pharmaceutical to pay cash dividend of 0.1 yuan per 10 shares (before tax) for 2017